Abstract
Sherven Sharma1,2† †Author for correspondence: 1Division of Pulmonary and Critical Care Medicine, UCLA Lung Cancer Program, School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1690, USA Tel.: +1 310 478 3711 ext. 41863 Fax: +1 310 268 4807 ssharma@mednet.ucla.edu 2Veterans Affairs Greater Los Angeles Healthcare System, CA, USA Towards effective immunotherapy for lung cancer: simultaneous targeting of tumor-initiating cells and immune pathways in the tumor microenvironment
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
